ProPhase Labs, Inc. — Director's Dealing 2019

Nov 22, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2019-11-20

Reporting Person: Brady Monica L. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-20	Option (right to buy)	$2.01	A	100000	Acquired	2026-11-19	Common Stock (100000)	Direct

Footnotes

F1: The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in four equal annual installments beginning November 20, 2019, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of November 20, 2019.